Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby,

Slides:



Advertisements
Similar presentations
Kamyar Kalantar-Zadeh  Kidney International 
Advertisements

Volume 66, Issue 4, Pages (October 2004)
Steven Fishbane, Jeffrey S. Berns, M.D.  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
Volume 59, Issue 3, Pages (March 2001)
Volume 88, Issue 5, Pages (November 2015)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label,
Iron status and iron supplementation in peritoneal dialysis patients
Propofol-related green urine
Anemia management in chronic kidney disease
Red blood cell life span and ‘erythropoietin resistance’
Volume 64, Pages S72-S77 (November 2003)
C-reactive protein and dialysis access
Determinants of phosphorus mobilization during hemodialysis
Volume 56, Issue 3, Pages (September 1999)
Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label,
C-reactive protein and dialysis access
Volume 63, Issue 6, Pages (June 2003)
Volume 54, Issue 2, Pages (August 1998)
Yasuhiro Hamada, Masafumi Fukagawa  Kidney International 
Kamyar Kalantar-Zadeh  Kidney International 
Volume 74, Issue 12, Pages (December 2008)
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
Dietary phosphorus is associated with greater left ventricular mass
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Nephrology Crosswords: Hemodialysis
Long-term study of mycophenolate mofetil treatment in IgA nephropathy
Volume 87, Issue 2, Pages (February 2015)
Volume 60, Issue 1, Pages (July 2001)
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Response to ‘Hepcidin levels in patients with renal disease’
Volume 65, Issue 6, Pages (June 2004)
Volume 58, Issue 3, Pages (September 2000)
Volume 78, Issue 2, Pages (July 2010)
Volume 75, Issue 11, Pages (June 2009)
Volume 73, Issue 9, Pages (May 2008)
Recent experience with high-dose intravenous iron administration
Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler 
The dynamics of prognostic indicators: toward earlier identification of dialysis patients with a high risk of dying  Charles Chazot, Guillaume Jean  Kidney.
Darbepoetin alfa (Aranesp™) in children with chronic renal failure
Volume 64, Pages S72-S77 (November 2003)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
Alternate-day dialysis may be needed for hemodialysis patients
Volume 55, Issue 4, Pages (April 1999)
Volume 78, Issue 8, Pages (October 2010)
Nephrology Crossword: Glomerulonephritis
Volume 56, Issue 5, Pages (November 1999)
Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis  N.-Y. Zalunardo, C.-L. Rose, I.W.Y.
Volume 80, Issue 3, Pages (August 2011)
Volume 55, Issue 5, Pages (May 1999)
Hemoglobin variability in epoetin-treated hemodialysis patients
Dosing darbepoetin alfa
Current status of maintenance hemodialysis in Beijing, China
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Volume 64, Issue 5, Pages (November 2003)
Volume 65, Issue 4, Pages (April 2004)
Volume 57, Issue 2, Pages (October 2000)
Volume 70, Issue 7, Pages (October 2006)
Thresholds of iron markers for iron deficiency erythropoiesis—finding of the Japanese nationwide dialysis registry  Takayuki Hamano, Naohiko Fujii, Terumasa.
Volume 75, Issue 9, Pages (May 2009)
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
Volume 70, Issue 5, Pages (September 2006)
Volume 59, Issue 3, Pages (March 2001)
Volume 76, Issue 5, Pages (September 2009)
Increased fetuin-A levels following treatment with a vitamin D analog
Volume 66, Issue 4, Pages (October 2004)
Presentation transcript:

Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients  Bradley A. Ford, Charles S. Eby, Mitchell G. Scott, Daniel W. Coyne  Kidney International  Volume 78, Issue 8, Pages 769-773 (October 2010) DOI: 10.1038/ki.2010.254 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of within-individual correlation (r-values) between hepcidin, ferritin, and CRP over 6 weeks. Circles: intra-individual correlations (r-values, Y axis) between hepcidin–ferritin, hepcidin–CRP, and ferritin–CRP over 6 weeks. Open circles: P>0.05; solid circles: P≤0.05. CRP, C-reactive protein; fer, ferritin; hep, hepcidin. Kidney International 2010 78, 769-773DOI: (10.1038/ki.2010.254) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 Individual trends in hepcidin and ferritin over 6 weeks. Open circles: hepcidin values. Closed circles: ferritin values. Left number: patient number. Y axis: change (%) over baseline. X axis: study week number, with half weeks over the first 2 weeks. (a) Patients with a significant intra-individual correlation in variation between hepcidin and ferritin. Patient 14 has a negative correlation; the others exhibit positive correlation. (b) Randomly selected patients with uncorrelated variation in hepcidin and ferritin. Kidney International 2010 78, 769-773DOI: (10.1038/ki.2010.254) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 3 Correlations between pairs of values across the entire study population. (a–d) Solid line; linear regression. Dashed lines; 95% confidence envelope for regression. (a–c) As labeled. (d) Average epoetin dose per week (units of epoetin alfa) vs the difference in the first and final measurements of serum hepcidin over 6 weeks. Kidney International 2010 78, 769-773DOI: (10.1038/ki.2010.254) Copyright © 2010 International Society of Nephrology Terms and Conditions